UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 6-K

 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of May 2010
 
Commission File Number: 1-32186
 
YM BIOSCIENCES INC.  
(Translation of registrant's name into English)
 
Suite 400, Building 11
5045 Orbiter Drive
Mississauga, Ontario
Canada L4W 4Y4
(Address of principal executive offices)
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F x
Form 40-F o
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1)   o
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7)   o
 
 
 
 
 
 
 
 
DOCUMENTS FILED

See the Exhibit Index hereto for a list of the documents filed herewith and forming a part of this Form 6-K.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
YM BIOSCIENCES INC.
   
   
  By: /s/ Leonard Vernon    
   
Leonard Vernon
Vice President, Finance and Administration
 
Date: May 21, 2010
 
 
 

 
 
 
EXHIBIT INDEX
 
Exhibit
 
Description
     
99.1
 
News Release dated May 21 , 2010 - YM BIOSCIENCES ANNOUNCES PRESENTATIONS ON GLOBAL NIMOTUZUMAB TRIALS AT ASCO ANNUAL MEETING

YM Biosciences (AMEX:YMI)
過去 株価チャート
から 6 2024 まで 7 2024 YM Biosciencesのチャートをもっと見るにはこちらをクリック
YM Biosciences (AMEX:YMI)
過去 株価チャート
から 7 2023 まで 7 2024 YM Biosciencesのチャートをもっと見るにはこちらをクリック